Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, a…
Industry Peers
Medical Devices| Headline | Source | Time |
|---|---|---|
Older | ||
MTD Second Quarter Earnings Beat Estimates on China-Led Sales Growth MTD beats Q2 earnings estimates as strong China and emerging-market sales fuel growth, while the company raises its 2026 sales and earnings outlook. | ||
EEFN | ||
Getinge Board Refresh Links Governance Shifts To Dividend And Growth Choices Getinge (OM:GETI B) plans significant board changes at its 2026 AGM. Shareholders are set to vote on the election of Camilla Sylvest to the board. New employee representatives are also expected to join the board, reshaping its composition. Getinge, a global provider of medical technology and life science solutions, is closely watched by investors who follow corporate governance and board expertise. Changes to the board at the 2026 AGM put the focus on how the company aligns oversight with... | ||
Getinge AB (GNGBY) Q1 2026 Earnings Call Highlights: Navigating Currency Headwinds and ... Despite currency and tariff challenges, Getinge AB (GNGBY) reports solid cash flow and strategic product launches to bolster future growth. | ||
HHallandsposten | ||
Getinge AB (GNGBF) Q4 2025 Earnings Call Highlights: Navigating Headwinds with Strategic Growth ... Despite currency and tariff challenges, Getinge AB (GNGBF) reports steady sales growth and a robust financial position, while focusing on high-margin products and strategic investments for 2026. | ||
MMedtech Magazine | ||
Does Getinge’s 29.3% Rally Signal Room for Growth After Healthcare Sector Headlines? Wondering if Getinge is a hidden gem or priced for perfection? You're not alone. Plenty of investors are curious about what the numbers really say about the stock's value. After climbing 3.5% in the last week and an impressive 29.3% over the past year, Getinge has captured fresh attention and debate about its growth prospects as well as potential risks. Much of this buzz has been fueled by recent healthcare sector headlines, including strategic acquisitions and shifts in medical technology... | ||
NCAB Group And 2 Other European Stocks That May Be Priced Below Intrinsic Value Estimates Amid concerns about global growth following weak U.S. jobs data and a stronger euro, the pan-European STOXX Europe 600 Index ended slightly lower, with mixed performances across major stock indexes. In this environment, identifying stocks that may be undervalued relative to their intrinsic value can offer potential opportunities for investors looking to capitalize on market inefficiencies. | ||
European Stocks That Might Be Trading Below Their Estimated Value In September 2025 As of September 2025, the European stock market has experienced mixed performance, with the pan-European STOXX Europe 600 Index slightly down amid global growth concerns and a stronger euro. Despite these challenges, inflation in the eurozone remains close to target, and unemployment rates have shown resilience, creating an environment where investors may find opportunities in stocks that are trading below their estimated value. Identifying such undervalued stocks often involves looking for... | ||
European Growth Companies With Strong Insider Ownership In September 2025 As of September 2025, the European market has seen mixed performance with the pan-European STOXX Europe 600 Index slightly down amid concerns about global growth and a stronger euro. Despite these challenges, certain growth companies in Europe stand out due to their strong insider ownership, which can be an indicator of confidence in long-term potential and alignment with shareholder interests. | ||
Heineken’s Strongbow adds NaviLens levels to packaging The cider brand has added a high-contrast NaviLens QR code to its cans. | ||
FFastighetsvärlden | ||